MONOMERIC FC DOMAINS

Anti-CD47 antibodies and uses thereof

THERAPEUTIC CANINE IMMUNOGLOBULINS AND METHODS OF USING SAME

ANTI-VEGF ANTIBODIES

Single domain serum albumin binding protein

GLYPICAN-3-SPECIFIC ANTIBODY AND USES THEREOF

HUMAN ANTI-TAU ANTIBODIES

Neutralizing antibodies to HIV-1 and their use

HUMAN NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (HNGAL) MUTEINS THAT BIND HEPCIDIN AND NUCLEIC ACID ENCODING SUCH

METHOD FOR AFFINITY PURIFICATION

Anti-DLL3 antibody drug conjugates

Multispecific and multifunctional molecules and uses thereof

Anti-TIM-3 antibodies and methods of use thereof

Non-human animals expressing pH-sensitive immunoglobulin sequences

Antibodies against BACE1 and use thereof for neural disease immunotherapy

Antibodies against immunogenic glycopeptides, compositions comprising the same and use thereof

TEM-1 diagnostic antibodies

Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use

Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof

CD6 antibody for treatment of T-cell mediated diseases or disorders

Human TNFRSF25 antibody

ANTI-TRKA ANTIBODIES WITH ENHANCED INHIBITORY PROPERTIES AND DERIVATIVES THEREOF FOR USE IN TREATING BONE ASSOCIATED PAIN

Compositions and Methods of Use for Therapeutic Low Density Lipoprotein-related protein 6 (LRP6) Antibodies

HUMANIZED ANTI-ALPHA V BETA 5 ANTIBODIES AND USES THEREOF

Anti-B7H3 binding compounds and uses thereof

Antibodies and immunocytokines

COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR HEMATOPOIETIC ORIGIN

Method of treating autoimmune disease by administering antibodies to interleukin-6

Human anti-IL-23 antibodies, compositions, methods and uses

Pan-ELR+ CXC chemokine antibodies

Anti-CXCL12 antibody molecules and their uses

VHH based binding antibodies for anthrax and botulinum toxins and methods of making and using therefor

Soluble universal ADCC-enhancing synthetic fusion gene and peptide technology and its use thereof

Cysteine linked nanobody dimers

Methods for the depletion of CD117+ cells

Biological materials and uses thereof

USE OF POLYACETYLENIC GLYCOSIDES FOR SUPPRESSION OF GRANULOCYTIC MYELOID-DERIVED SUPPRESSOR CELL ACTIVITIES AND TUMOR METASTASIS

Efficacy of anti-HLA-DR antiboddy drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR positive cancers

MONOCLONAL AND OLIGOCLONAL ANTI-EGFR ANTIBODIES FOR USE IN THE TREATMENT OF TUMORS EXPRESSING PREDOMINANTLY HIGH AFFINITY EGFR LIGANDS OR TUMORS EXPRESSING PREDOMINANTLY LOW AFFINITY EGFR LIGANDS

ANTIBODIES TO CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE (CEACAM)

Anti-coagulation factor XI antibodies

METHODS OF USING BISPECIFIC ANTIGEN-BINDING CONSTRUCTS TARGETING HER2

Monoclonal antibodies and methods of use

Anti-GITR antibodies and uses thereof

Anti-TNFRSF25 antibodies

Anti-GITR antibodies

Anti-GPIIB/IIIA antibodies and uses thereof

PD-L1 specific monoclonal antibodies for disease treatment and diagnosis

Anti-B7-H3 antibodies and antibody drug conjugates

Bispecific antibodies against CD3 and CD20

TEM8 antibodies and their use in treatment and detection of tumors

METHODS FOR THE TREATMENT OF GOUT

Use of IL-31 monoclonal antibodies for reducing pruritus

IL-17 antagonistic antibodies

Anti-PHF-tau antibodies and their uses

Anti-C5 antibodies

Human antibodies to Ebola virus glycoprotein

High-throughput screening of functional antibody fragments, immunoconjugate comprising the same, and adaptor-drug conjugate for screening

Modified Fab region-binding peptide

Animal models and therapeutic molecules

MULTISPECIFIC ANTIBODIES

C-MET ANTIBODY COMBINATIONS

Combination therapy of T cell activating bispecific antigen binding molecules and PD-1 axis binding antagonists

ANTI-CD52 ANTIBODIES

BISPECIFIC ANTIBODIES THAT BIND CD123 AND CD3

Anti-Axl antagonistic antibodies

BISPECIFIC ANTIBODIES THAT BIND CD20 AND CD3

PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGENIC DISEASE

IMMUNOGLOBULINS WITH REDUCED AGGREGATION

Compositions and methods for treating and preventing infections

Composite comprising antibody capable of binding to intranuclear protein of influenza virus

Methods for formulating antibody drug conjugate compositions

TfR selective binding compounds and related methods

Compositions and methods for treating cocaine-related disorders

ANTI-HtrA1 ANTIBODIES AND METHODS OF USE

MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)

Fusion protein comprising three binding domains to 5T4 and CD3

Anti-CD40 antibodies

Humanized Anti-CD70 Binding Agents and Uses Thereof

Methods for treating subjects having a CXC chemokine receptor 5 (CXCR5)-responsive cancer by administering fully human anti-CXCR5 antibodies

Fusion polypeptide capable of binding simultaneously to VEGF-C and VEGF-D

ANTI-GLYCOPROTEIN IIb/IIIa ANTIBODIES

Anti-chondroitin sulfate proteoglycan 4 antibodies and uses thereof

Anti IL-34 antibodies

Antibodies for IL-17C

Engineered anti-TGF-β antibodies and antigen-binding fragments

Anti-NGF antibodies and methods using same

MONOCLONAL ANTIBODY AGAINST MURAMYL PEPTIDES IN PREVENTION AND TREATMENT OF IMMUNE-MEDIATED DISEASES

Cytotoxic benzodiazepine derivatives

Cytotoxic benzodiazepine derivatives

Interleukin-13 binding proteins

Anti-TIGIT antigen-binding proteins and methods of use thereof

Human antibodies to Middle East Respiratory Syndrome—coronavirus spike protein

Proteinaceous heterodimer and use thereof

NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS

Antibodies specific for urokinase-type plasminogen activator and methods of use thereof for treating cancer

Anti-CD39 antibodies and uses thereof

CD83 binding proteins and uses thereof

Anti-endoglin antibodies and uses thereof

FN14-binding proteins and uses thereof

Methods of treating conditions with antibodies that bind B7-H4

Single chain variable fragment CD3 binding proteins

Antibody molecules for cancer treatment

Treatment of pediatric BCP-ALL patients with an anti-KIR antibody

ANTIBODIES TO NTB-A

Bak binding proteins

Anti-ACTH antibodies and use thereof

Antagonists of IL-6 to raise albumin and/or lower CRP

ANTI-IL-13/IL-17 BISPECIFIC ANTIBODIES AND USES THEREOF

Human monoclonal antibodies against interleukin 8 (IL-8)

Sequences directed against hepatocyte growth factor (HGF) and polypeptides comprising the same for the treatment of cancers and/or tumors

ANTI-PROPERDIN ANTIBODIES AND USES THEREOF

Single domain serum albumin binding protein

Anti-complement factor C1q antibodies and uses thereof

Non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies directed against envelope glycoproteins

Human cytomegalovirus neutralizing antibodies and use thereof

Catheter package including catheter straightening means

Anti-pro/latent-myostatin antibodies and uses thereof

Dosage and administration of non-fucosylated anti-CD40 antibodies

Method for generating high affinity antibodies

Methods of treating comprising administering anti-OX40L antibodies

BISPECIFIC ANTIBODIES AGAINST CD3 EPSILON AND BCMA FOR USE IN TREATMENT OF DISEASES

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA

Anti P2X7 receptor antibodies and fragments thereof

Folate receptor 1 antibodies and immunoconjugates and uses thereof

Anti-human IL-17 monoclonal antibodies and use thereof

Anti-TNF-α fully human monoclonal antibodies with low immunogenicity and application thereof

Angiopoietin 2, VEGF dual antagonists

Anti-NGF compositions and use thereof

ANTIBODY-DRUG CONJUGATE OF AN ANTI-GLYPICAN-3 ANTIBODY AND A TUBULYSIN ANALOG, PREPARATION AND USES

CROSSLINKING OF CD22 BY EPRATUZUMAB TRIGGERS BCR SIGNALING AND CASPASE-DEPENDENT APOPTOSIS IN HEMATOPOIETIC CANCER CELLS

Epitope of hepatitis B virus surface antigen and binding molecule specifically binding to same for neutralizing hepatitis B virus

Trispecific and/or trivalent binding proteins

Humanized monoclonal antibody and uses thereof

MONOCLONAL ANTIBODIES AGAINST C-MET

Anti-MFI2 antibodies and methods of use

MULTIVALENT AND MULTISPECIFIC GITR-BINDING FUSION PROTEINS

Methods of inhibiting T-cell mediated B-cell antibody production using anti-CD27 antibodies

ANTI-LIGHT ANTIBODIES

Antibodies against human CSF-1R and uses thereof

Anti-vista antibodies and fragments, uses thereof, and methods of identifying same

Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof

Heterodimeric antibodies that bind CD3 and PSMA

Anti-NTB-A antibodies and related compositions and methods

ANTIBODY-DRUG CONJUGATES

Targeted liposomal gemcitabine compositions and methods thereof

ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF

MONOCLONAL ANTIBODIES AGAINST C-MET

MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF

ICOS BINDING PROTEINS

Antigen binding proteins that bind PD-1

Anti-PD-1 antibodies

Treatment of cancers using anti-NKG2A agents

Interferon beta antibodies and uses thereof

Method of treating pruritus with IL-31 monoclonal antibody formulations

INFLUENZA A VIRUS SPECIFIC ANTIBODIES

Hepatitis C virus specific antibody

NOVEL CHIMERIC ANTIGEN RECEPTORS

Compositions relating to a mutant toxin and methods thereof

Kits containing DLL3 antibody drug conjugates

Bispecific antibody format

Method of treating inflammation by administering antibody molecules which bind IL-17A and IL-17F

Anti-HER3 antibodies and uses of same

Antibody therapeutics that bind STAT3

GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1 FOR USE IN THE TREATMENT OF OVARIAN CANCER

Methods of treating cancer in a patient by administering anti-folate-receptor-1 (FOLR1) antibodies

COMPOSITIONS AND METHODS OF USE FOR AUGMENTED IMMUNE RESPONSE AND CANCER THERAPY

Compositions and methods of use for augmented immune response and cancer therapy

Bispecific antibodies against CD3ϵ and BCMA

Antibodies against OX40 and uses thereof

Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereof

Binding proteins and methods of use thereof

WNT signaling agonist molecules

ALK7 binding proteins and uses thereof

Anti-human vista antibodies and use thereof

Anti-human vista antibodies and use thereof

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

Anti-human vista antibodies and use thereof

Anti-CD100 antibodies and methods for using the same

Binding molecules, especially antibodies, binding to L1CAM (CD171)

Monoclonal antibodies to progastrin and their uses

Monoclonal antibodies to progastrin and their uses

Anti-tenascin C antibodies and uses thereof

COMPOSITIONS AND METHODS RELATED TO ANTIBODIES THAT NEUTRALIZE COAGULASE ACTIVITY DURING STAPHYLOCOCCUS AUREUS DISEASE

Agents for influenza neutralization

EGFR and c-Met fibronectin type III domain binding molecules

Antagonistic DR3 Ligands

Fab REGION-BINDING PEPTIDE

Methods of treating RSV infections

Inhalation device for use in aerosol therapy of respiratory diseases

Glucocorticoid-induced tumor necrosis factor receptor (GITR) antibodies and methods of use thereof

Antigen binding proteins that bind WISP1

Trispecific binding proteins and methods of use

Anti-inflammatory agents

RSPO BINDING AGENTS AND USES THEREOF

COMPOSITIONS OF ANTIBODY CONSTRUCT-AGONIST CONJUGATES AND METHODS OF USE THEREOF

ANTI IL-36R ANTIBODIES

Treatment regimens using anti-NKG2A antibodies

Site directed mutagenesis of TREM-1 antibodies for decreasing viscosity

Anti-PACAP antibodies and uses thereof

Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof

Anti-C5 antibodies having improved pharmacokinetics

Antigen associated with rheumatoid arthritis

Anti-serum albumin binding variants

Antibodies that bind Ebola glycoprotein and uses thereof

ANTIBODY MOLECULES TO ZIKA VIRUS AND USES THEREOF

Humanized anti-PACAP antibodies and uses thereof

Methods for Treating Hypercholesterolemia and Reducing LDL-C Using Antibodies to PCSK9

COMBINATION OF HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES

Specific delivery of agrochemicals

Antibody therapeutics that bind CD38

USE OF ERBB3 INHIBITORS IN THE TREATMENT OF TRIPLE NEGATIVE AND BASAL-LIKE BREAST CANCERS

Bispecific HER2 antibodies

Carrier-binding agent compositions and methods of making and using the same

Anti-LIGHT antibodies

Antibody therapeutics that bind CD123

Antibody binding to neuropilin 1 and use thereof

Diagnostic method for determining the presence and amount of human interleukin-3 in a sample using novel IL-3 antibodies

IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

ANTIBODIES SPECIFIC FOR IL-17A FUSED TO HYALURONAN BINDING PEPTIDE TAGS

Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging

Antibody-drug conjugate having cyclic benzylidene acetal linker

ANTI-LAG3 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS

Anti-IL-23 antibodies, compositions, methods and uses

Humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereof

COMPLIMENT FACTOR I BIOASSAY

Murine, chimeric, humanized or human anti-IL-6 antibodies

Methods for inhibiting angiogenesis in a subject in need thereof

BCMA binding molecules and methods of use thereof

Antigen binding proteins that bind c-met

Anti-hepcidin antibodies and uses thereof

Immuno-based botulinum toxin serotype A activity assays

Stable immunogen based on inner domain of HIV-1 gp120 for inducing immunity against HIV

Anti-TEM1 antibodies and uses thereof

Anti-mesothelin antibodies and immunoconjugates

Antibodies to TIGIT

UNIVERSAL PLATFORM FOR TARGETING THERAPIES TO TREAT NEUROLOGICAL DISEASES

Multivalent CD20-binding molecule comprising Shiga toxin A subunit effector polypeptides and enriched compositions thereof

DETECTION OF A POLYPEPTIDE DIMER BY A BIVALENT BINDING AGENT

Monoclonal antibody, inhibiting the enzymatic activity of vascular endothelial lipase

Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists

ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF

ALPHA-4-BETA-7 HETERODIMER SPECIFIC ANTAGONIST ANTIBODY

Humanized anti-CD22 antibody

Chimeric antigen receptors targeting Fc receptor-like 5 and uses thereof

Serum albumin binding proteins containing immunoglobulin single variable domains

Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains

ANTI-EPHRINB2 ANTIBODIES AND METHODS USING SAME

IL-23p19 monoclonal antibodies

NEUTRALISING ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN IL-17

Antibodies to M-CSF

Trispecific inhibitors for cancer treatment

Methods of Treating Chronic Pain

Anti-DLL3 antibody drug conjugates

COMBINING ANTI-HLA-DR OR ANTI-TROP-2 ANTIBODIES WITH MICROTUBULE INHIBITORS, PARP INHIBITORS, BRUTON KINASE INHIBITORS OR PHOSPHOINOSITIDE 3-KINASE INHIBITORS SIGNIFICANTLY IMPROVES THERAPEUTIC OUTCOME IN CANCER

Immunoconjugates comprising anti-HER2 antibodies and pyrrolobenzodiazepines

Cytotoxicity-inducing theraputic agent

Methods for treating conditions associated with MASP-2 dependent complement activation

MOLECULES WITH ALTERED NEONATE FC RECEPTOR BINDING HAVING ENHANCED THERAPEUTIC AND DIAGNOSTIC PROPERTIES

Humanized anti-Tn-MUC1 antibodies and their conjugates

RSPO3 Binding Agents and Uses Thereof

CD27L antigen binding proteins

Site-specific antibody-drug conjugation through glycoengineering

AGONISTIC ANTIBODY TO CD27

ST2 antigen binding proteins

IGF-1R antibody and its use as addressing vehicle for the treatment of cancer

Anti-EGFR antibody and uses of same

ANTI-MICA ANTIBODIES

Anti PD-1 antibodies

Anti-sortilin antibodies, uses and methods for treatment

Anti-LAG3 antibodies and antigen-binding fragments

Composition for preventing or treating lung cancer comprising antibody against CD66C and chemotherapeutic agent

ISOLATED ANTI-MESOTHELIN ANTIBODIES, CONJUGATES AND USES THEREOF

Method of Treating Ovarian and Renal Cancer Using Antibodies Against T Cell Immunoglobulin Domain and Mucin Domain 1 (TIM-1) Antigen

Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein

Anti-DLL3 antibody drug conjugates for treating cancer

Methods of making DLL3 antibody drug conjugates

Methods of delivering DLL3 antibody drug conjugates

Anti-DLL3 antibody drug conjugates

LOW AFFINITY BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES AND USES THEREOF

Chemically-locked bispecific antibodies

Humanized monoclonal antibody, inhibiting the enzymatic activity of vascular endothelial lipase

Antibodies capable of binding two epitopes on tissue factor pathway inhibitor (1-161)

GITR antibodies, methods, and uses

Antibodies that Bind to OX40 and Their Uses

Methods of inhibiting pathological angiogenesis with doppel-targeting molecules

Construct for the delivery of a molecule into the cytoplasm of a cell

Anti-c-Met/anti-Ang2 bispecific antibody

Methods of treating cardiovascular disorders with lectin-like oxidized LDL receptor 1 antibodies

Methods of treating atopic dermatitis with IL-31 monoclonal antibodies

TSLP BINDING PROTEINS

Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases

ANTIBODIES AGAINST NERVE GROWTH FACTOR (NGF) WITH ENHANCED IN VIVO STABILITY

Compositions and methods for antibodies targeting complement protein C5

Monoclonal antibody against muramyl peptides

Antibody binding specifically to pre-S1 of hepatitis B virus and use of the antibody

Pyrrolobenzodiazepine-antibody conjugates

REMOVAL OF MONOMERIC TARGETS